The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2

Adam D. Longhurst, Kyle Wang, Harsha Garadi Suresh, Mythili Ketavarapu, Henry N. Ward,Ian R. Jones,Vivek Narayan, Frances V. Hundley, Arshia Zernab Hassan, Charles Boone,Chad L. Myers, Yin Shen,Vijay Ramani, Brenda J. Andrews,David P. Toczyski

biorxiv(2024)

引用 0|浏览0
暂无评分
摘要
Progression through the G1 phase of the cell cycle is the most highly regulated step in cellular division. We employed a chemogenomics approach to discover novel cellular networks that regulate cell cycle progression. This approach uncovered functional clusters of genes that altered sensitivity of cells to inhibitors of the G1/S transition. Mutation of components of the Polycomb Repressor Complex 2 rescued growth inhibition caused by the CDK4/6 inhibitor palbociclib, but not to inhibitors of S phase or mitosis. In addition to its core catalytic subunits, mutation of the PRC2.1 accessory protein MTF2, but not the PRC2.2 protein JARID2, rendered cells resistant to palbociclib treatment. We found that PRC2.1 (MTF2), but not PRC2.2 (JARID2), was critical for promoting H3K27me3 deposition at CpG islands genome-wide and in promoters. This included the CpG islands in the promoter of the CDK4/6 cyclins CCND1 and CCND2, and loss of MTF2 lead to upregulation of both CCND1 and CCND2. Our results demonstrate a role for PRC2.1, but not PRC2.2, in promoting G1 progression. ### Competing Interest Statement The authors have declared no competing interest.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要